AzTrials
AzTrials

Ischemic Heart DiseaseEASY-PRIPCINCT04494750

Physiology and Residual Ischemia After Percutaneous Coronary Intervention

An observational study of Ischemic Heart Disease and Angina Pectoris, run by Laval University at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Despite optimal angiographic result after stent implantation, a number of patients will undergo repeat angiography within 1 year of index procedure. EASY-PRIPCI is an observational study evaluating the incidence of abnormal physiology results in patients undergoing repeat angiography after uncomplicated percutaneous… Read more about this study

Who is it for?
Ages 18 years and older
How many people
260 participants
Where
1 siteCanada
Study dates
18 Feb 2021to Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients returning to the Quebec Heart Institute for a diagnostic angiography and possible PCI within 12 months of a previous uncomplicated PCI with stent implantation.

Who may be able to join

  • Any patient referred for diagnostic angiography and possible PCI within 12 months of uncomplicated PCI with stent implantation.

Who cannot join

  • Unable to understand study design or objectives of study.
  • Unable to sign informed consent.
  • Evidence of in-stent restenosis or significant untreated coronary lesions (initial incomplete revascularization)
  • Inability to comply with the study follow-up

Trial locations and contacts

1 site in 1 country.

Olivier F. Bertrand, MD, PhD contact

+14186568711 ext. 5947

olivier.bertrand@chul.ulaval.ca

Canada1 site, 1 recruiting
  • IUCPQ - Laval Hospital

    Québec, G1V 4G5

    Olivier F Bertrand, MD PhD, 418 656 8711, olivier.bertrand@crhl.ulaval.ca

    Olivier F Bertrand, MD PhD

    Recruiting

Other trials in Canada

About this study

Official title: Physiology and Residual Ischemia After Percutaneous Coronary Intervention (EArly Discharge After Transradial Stenting of CoronarY Arteries- EASY- PRIPCI)

Despite optimal angiographic result after stent implantation, a number of patients will undergo repeat angiography within 1 year of index procedure. EASY-PRIPCI is an observational study evaluating the incidence of abnormal physiology results in patients undergoing repeat angiography after uncomplicated percutaneous intervention (PCI).

Read the detailed description

Despite successful PCI and complete revascularization, about 25% of patients will present with angina and/or positive exercise testing during follow-up. With recurring or persistent symptoms, a number of those patients will be referred for control angiography. This might create a significant burden for health systems as well as putting patients to undergo further interventions without clear demonstration of ischemia.

Assessing physiology and fractional flow reserve in particular after PCI could represent a further step to determine whether stent implantation and stenosis removal will be effective to relieve subjective and objective signs of ischemia.

Hypothesis:

Resting gradients such as whole cycle Pd/Pa and diastolic dPR and FFR will be abnormal (below ischemic threshold) in > 20% of cases despite optimal stent implantation and angiographic result.

The use of physiology assessment in previously intervened vessels in patients referred for persisting or recurring angina might help operators to decide upon further intervention.

Keywords
Coronary Artery Disease, Fractional Flow Reserve (FFR), Coronary physiology, Repeat intervention, diastolic pressure ratio (dPR)
Medical subject headings
Myocardial Ischemia, Angina Pectoris, Chest Pain, Coronary Artery Disease, Coronary Restenosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of successful uncomplicated PCI as per coronary physiology ratios

    Record the minimal values reported for Pd/Pa, dPR and FFR ratios in the distal vessel after uncomplicated PCI and good angiographic result.Comparison between baseline (pre PCI) and final (post PCI) coronary physiology ratios .

    Measured: Transprocedural, initial and final values

Secondary outcomes (4)
  1. Incidence and types of further interventions or imaging techniques

    Record the incidence by type of intervention and diagnostic or imaging techniques

    Measured: Historical and immediately after the procedure, up to 36 months

  2. Residual symptoms and quality of life after repeat angiography

    Identify residual symptoms after intervention, and overall immediate quality of life.

    Measured: up to 30 days

  3. Rates of repeat interventions

    on previously intervened lesions versus PCI on new lesions

    Measured: Historical and immediately after the procedure

  4. Incidence of successful distal positioning of pressurewire

    Measured: Transprocedural

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jul 2020
  2. Study start18 Feb 2021
  3. Primary completionOct 2023 (estimated)
  4. Study completionDec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case crossover
Time perspective
Cross-sectional
Enrolment
260 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04494750
Sponsor's protocol ID
EASY-PRIPCI
Acronym
EASY-PRIPCI
Status last verified
Jan 2022
First submitted
27 Jul 2020
Last updated
31 Jan 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Ischemic Heart Disease and Angina Pectoris, run by Laval University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Olivier F. Bertrand, MD, PhD (+14186568711 ext. 5947, olivier.bertrand@chul.ulaval.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of successful uncomplicated PCI as per coronary physiology ratios (time frame: Transprocedural, initial and final values). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in